FDA DISCLAIMER - The statements and products referred to throughout this site have not been evaluated by the FDA. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult a physician or your health care provider. Always consult a medical doctor before modifying your diet, using any new product, drug, supplement, or doing new exercises. We recommend you educate yourselves on the scientific / nutritional facts.
The human body is made up of the Endogenous Cannabinoid System (ECS) which is responsible for the synaptic plasticity, neuromodulation, and development of the central nervous system and the peripheral system. The ECS consists of cannabinoid receptors among other substances that respond to the intake of different cannabinoid substances. The receptors can be found in various parts of the body. There are over 65 molecular targets of Cannabidiol in the human body. These target locations and receptors allow CBD oil to deliver its therapeutic benefits to the individual without any need to worry about any euphoric effect (caused by THC). For CBD to properly function, it is necessary that it is the important substance in any CBD based product; the higher the concentration of CBD in a product, the better your chances of enjoying its maximum benefits.
Maintaining an optimal level of wellness is absolutely crucial to live a higher quality life. Wellness matters. Wellness matters because everything we do and every emotion we feel relates to our well-being. In turn, our well-being directly affects our actions and emotions. It’s an ongoing circle. Therefore, it is important for everyone to achieve optimal wellness in order to subdue stress, reduce the risk of illness and ensure positive interactions.
Blessing and Haney agree that the current evidence suggests that CBD shows promise for helping to treat some illnesses. In June 2018, the Food and Drug Administration (FDA) approved the first cannabis-derived drug — Epidiolex, which contains purified CBD — to treat certain rare childhood seizure syndromes. However, much of the research on CBD is only in very early stages, and scientists still don’t know a lot about it — including whether it has negative long-term effects.
To make matters more confusing, nine states (including California, Washington, and Colorado) let residents buy cannabis-based products with or without THC. Nearly two dozen other “medical marijuana states” allow the sale of cannabis, including capsules, tinctures, and other items containing CBD or THC, at licensed dispensaries to people whose doctors have certified that they have an approved condition (the list varies by state but includes chronic pain, PTSD, cancer, autism, Crohn’s disease, and multiple sclerosis). Sixteen more states legalized CBD for certain diseases. But because all these products are illegal according to the federal government, cannabis advocates are cautious. “By and large, the federal government is looking the other way,” says Paul Armentano, deputy director of the Washington, DC–based National Organization for the Reform of Marijuana Laws (NORML), but until federal laws are changed, “this administration or a future one could crack down on people who produce, manufacture, or use CBD, and the law would be on its side.”
The results “suggest CBD to be a potential treatment for nicotine addiction,” the study authors wrote—but they also admit that their findings are preliminary. Ryan Vandrey, PhD, a cannabis researcher and associate professor of psychiatry at Johns Hopkins University (who was not involved in the 2013 study), agrees that larger, longer-term studies are needed to know if CBD might be helpful for smokers looking to kick the habit.